NCT02223481
- Conditions
- Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +3 more
- Locations
-
Not specified
Clinical trial condition
Hypertension, Pulmonary
Explore clinical trials studying Hypertension, Pulmonary. Study availability and eligibility vary by location and protocol.
121 public trials
5 recruiting studies
Hypertension, Pulmonary trial results
NCT00820352
- Conditions
- Cardiovascular Diseases, Heart Diseases, Heart Failure, +6 more
- Locations
-
- Hospital Mostviertel Waidhofen/Ybbs Waidhofen an der Thaya, Lower Austria, Austria
- University Teaching Hospital Hall i.T. Hall I. T., Tyrol, Austria
- University Teaching Hospital of the Elisabethinen, Linz Linz, Upper Austria, Austria
- Hospital Wels/Grieskirchen Wels, Upper Austria, Austria
NCT01038284
- Conditions
- Cardiovascular Diseases, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, +5 more
- Locations
-
- CHU Bordeaux Bordeaux, France
- CHU Brest Brest, France
- Hopital Antoine Beclere Clamart, France
- Clinical Research Center Inserm CIC03 - Grenoble University Hospital Grenoble, France
NCT00000623
- Conditions
- Anemia, Anemia, Cooley's, Anemia, Hemolytic, +23 more
- Locations
-
- Children's Hospital Oakland Oakland, California, United States
- Children's Hospital Boston, Massachusetts, United States
- Weill Medical College of Cornell University New York, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
Completed
Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension
NCT00872170
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +12 more
- Locations
-
- Children's Hospital and Research Institute Oakland Oakland, California, United States
Completed
Milrinone Inhaled in Cardiac Surgery
NCT00819377
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +11 more
- Locations
-
- Montreal Heart Institute Montreal, Quebec, Canada
NCT01281371
- Conditions
- Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +3 more
- Locations
-
- Department of Clinical Pharmacology and Pharmacoepidemiology, Medical department of the University of Heidelberg Heidelberg, Baden-Wurttemberg, Germany
NCT01121458
- Conditions
- Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +3 more
- Locations
-
- VA North Texas Health Care System Dallas, Texas, United States
NCT00549302
- Conditions
- Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +3 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bend, Oregon, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brussels, Belgium
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toronto, Ontario, Canada
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lille, France
NCT00554619
- Conditions
- Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +4 more
- Locations
-
- GSK Investigational Site Aichi, Japan
- GSK Investigational Site Hokkaido, Japan
- GSK Investigational Site Hokkaido, Japan
- GSK Investigational Site Ishikawa, Japan